Tag: DCGI
Cipla launches remdesivir under brand name CIPREMI
Cipla announced the launch of remdesivir under its brand name CIPREMI. The USFDA issued an Emergency Use Authorization (EUA) to Gilead Sciences for emergency...
Umifenovir gets DCGI approval for Phase III clinical trial
CSIR constituent lab CSIR-Central Drug Research Institute (CDRI) Lucknow has received permission for carrying out Phase III randomized, Double-blind, Placebo-controlled trial of efficacy, safety,...
Glenmark receives approval from DCGI to conduct clinical trials in India
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced that it has received approval from the DCGI (Drug Controller General of India), the regulator...